Literature DB >> 3512762

Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis.

S M Wahl, D A Hunt, J B Allen, R L Wilder, L Paglia, A R Hand.   

Abstract

In vitro studies implicate a molecular link between inflammatory mononuclear cells and alterations in fibroblast growth and function. We have extended these observations in an experimental animal model in which we document the T cell-dependence of fibrosis that occurs after activation of the cell-mediated immune system by specific antigen. Chronic granulomatous lesions were induced in the livers of susceptible rats by the intraperitoneal injection of group A streptococcal cell walls (SCW). The development of granulomas that are composed primarily of lymphocytes and macrophages was associated with the recruitment and proliferation of connective tissue cells. Furthermore, this expanded population of fibroblasts generated a collagenous structure consisting primarily of types I and III collagen around the granuloma. The progression of these chronic inflammatory lesions leads to the formation of fibrotic nodules throughout the livers of the treated animals. Intact granulomas, as well as mononuclear cells derived from the granulomas, spontaneously elaborated a soluble factor(s) that stimulates fibroblast proliferation. Physicochemical analysis revealed that the primary granuloma-derived peak of fibroblast growth activity corresponded to an apparent Mr of 40,000, which is consistent with a previously described T lymphocyte--derived fibroblast-activating factor (FAF) in guinea pig and human. Furthermore, the fibrosis that occurs in the granuloma is apparently T cell--dependent, since no fibrotic lesions developed in SCW-injected athymic nude rats nor in SCW-injected animals treated with the T cell inhibitor, cyclosporin A (CsA). Mononuclear cells from neither of these functionally T cell--deficient animals could generate FAF activity. These data show a role for T lymphocyte--derived cytokines in the development of hepatic fibrosis in SCW-injected rats.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512762      PMCID: PMC2188069          DOI: 10.1084/jem.163.4.884

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

2.  Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules.

Authors:  A E Postlethwaite; G N Smith; C L Mainardi; J M Seyer; A H Kang
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

3.  The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Comparative studies in arthritis resistant and susceptible inbred rat strains.

Authors:  R L Wilder; J B Allen; L M Wahl; G B Calandra; S M Wahl
Journal:  Arthritis Rheum       Date:  1983-12

4.  Macrophage-derived growth factor for fibroblasts and Interleukin-1 are distinct entities.

Authors:  J E Estes; W J Pledger; G Y Gillespie
Journal:  J Leukoc Biol       Date:  1984-01       Impact factor: 4.962

5.  Fibroblast stimulation in schistosomiasis. V. Egg granuloma macrophages spontaneously secrete a fibroblast-stimulating factor.

Authors:  D J Wyler; M J Stadecker; C A Dinarello; J F O'Dea
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Induction of interleukin 2 messenger RNA inhibited by cyclosporin A.

Authors:  J F Elliott; Y Lin; S B Mizel; R C Bleackley; D G Harnish; V Paetkau
Journal:  Science       Date:  1984-12-21       Impact factor: 47.728

7.  Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.

Authors:  M Krönke; W J Leonard; J M Depper; S K Arya; F Wong-Staal; R C Gallo; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Modulation of fibroblast growth by a lymphokine of human T cell continuous T cell line origin.

Authors:  S M Wahl; C L Gately
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

9.  Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction.

Authors:  S M Wahl; D G Malone; R L Wilder
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

10.  Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.

Authors:  A Granelli-Piperno; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Hepatobiliary injury associated with experimental small-bowel bacterial overgrowth in rats.

Authors:  S N Lichtman; R B Sartor
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Amelioration of chronic inflammation by ingestion of elemental diet in a rat model of granulomatous enteritis.

Authors:  S Tanaka; S Miura; H Kimura; N Ohkubo; Y Tsuzuki; D Fukumura; H Serizawa; I Kurose; M Mori; H Ishii
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

3.  Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers.

Authors:  H H Herfarth; S P Mohanty; H C Rath; S Tonkonogy; R B Sartor
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

4.  Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica.

Authors:  R K Kumar
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

Review 5.  Colony-stimulating factors in the pathogenesis and treatment of disease.

Authors:  D J Williamson; C G Begley
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

6.  Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats.

Authors:  R B Sartor; S K Anderle; N Rifai; D A Goo; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

7.  Role of Kupffer cells in developing streptococcal cell wall granulomas. Streptococcal cell wall induction of inflammatory cytokines and mediators.

Authors:  C L Manthey; T Kossmann; J B Allen; M L Corcoran; M E Brandes; S M Wahl
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

8.  Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis.

Authors:  J W Fuseler; E M Conner; J M Davis; R E Wolf; M B Grisham
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

9.  Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis.

Authors:  E Simelyte; M Rimpiläinen; X Zhang; P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

Review 10.  Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.

Authors:  J H Schwab
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.